Biopharmaceutical research companies have been and continue to be a source of quality jobs, tax revenue and research spending in Wisconsin. A TEConomy Partners study found that the biopharmaceutical sector:
A separate study by TEConomy Partners found that in 2017 alone, there were 409 active industry-sponsored clinical trials in Wisconsin, with an estimated enrollment of 6,811 Wisconsin residents. Cardiovascular and circulatory diseases were the largest clinical trial disease area by total estimated enrollment in the state.
The investment at clinical trial sites was more than $90 million and the estimated total economic impact was more than $273 million.